EPHA7
Ephrin type-A receptor 7
Also known as: EPHA7_HUMAN, Hek11
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q15375
- Gene
- EPHA7
- Ensembl
- ENSG00000135333
- Chromosome
- 6
- Canonical length
- 998 aa
- Protein class
- Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins
- Subcellular location
- Principal piece
- Secretome location
- Intracellular and membrane
OverviewNCBI Gene
This gene belongs to the ephrin receptor subfamily of the protein-tyrosine kinase family. EPH and EPH-related receptors have been implicated in mediating developmental events, particularly in the nervous system. Receptors in the EPH subfamily typically have a single kinase domain and an extracellular region containing a Cys-rich domain and 2 fibronectin type III repeats. The ephrin receptors are divided into 2 groups based on the similarity of their extracellular domain sequences and their affinities for binding ephrin-A and ephrin-B ligands. Increased expression of this gene is associated with multiple forms of carcinoma. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Dec 2013]
Canonical amino-acid sequenceUniProt
998 residues, UniProt reviewed canonical sequence.
>Q15375|EPHA7
1 MVFQTRYPSW IILCYIWLLR FAHTGEAQAA KEVLLLDSKA QQTELEWISS PPNGWEEISG
61 LDENYTPIRT YQVCQVMEPN QNNWLRTNWI SKGNAQRIFV ELKFTLRDCN SLPGVLGTCK
121 ETFNLYYYET DYDTGRNIRE NLYVKIDTIA ADESFTQGDL GERKMKLNTE VREIGPLSKK
181 GFYLAFQDVG ACIALVSVKV YYKKCWSIIE NLAIFPDTVT GSEFSSLVEV RGTCVSSAEE
241 EAENAPRMHC SAEGEWLVPI GKCICKAGYQ QKGDTCEPCG RGFYKSSSQD LQCSRCPTHS
301 FSDKEGSSRC ECEDGYYRAP SDPPYVACTR PPSAPQNLIF NINQTTVSLE WSPPADNGGR
361 NDVTYRILCK RCSWEQGECV PCGSNIGYMP QQTGLEDNYV TVMDLLAHAN YTFEVEAVNG
421 VSDLSRSQRL FAAVSITTGQ AAPSQVSGVM KERVLQRSVE LSWQEPEHPN GVITEYEIKY
481 YEKDQRERTY STVKTKSTSA SINNLKPGTV YVFQIRAFTA AGYGNYSPRL DVATLEEATG
541 KMFEATAVSS EQNPVIIIAV VAVAGTIILV FMVFGFIIGR RHCGYSKADQ EGDEELYFHF
601 KFPGTKTYID PETYEDPNRA VHQFAKELDA SCIKIERVIG AGEFGEVCSG RLKLPGKRDV
661 AVAIKTLKVG YTEKQRRDFL CEASIMGQFD HPNVVHLEGV VTRGKPVMIV IEFMENGALD
721 AFLRKHDGQF TVIQLVGMLR GIAAGMRYLA DMGYVHRDLA ARNILVNSNL VCKVSDFGLS
781 RVIEDDPEAV YTTTGGKIPV RWTAPEAIQY RKFTSASDVW SYGIVMWEVM SYGERPYWDM
841 SNQDVIKAIE EGYRLPAPMD CPAGLHQLML DCWQKERAER PKFEQIVGIL DKMIRNPNSL
901 KTPLGTCSRP ISPLLDQNTP DFTTFCSVGE WLQAIKMERY KDNFTAAGYN SLESVARMTI
961 EDVMSLGITL VGHQKKIMSS IQTMRAQMLH LHGTGIQVLocalizationUniProt · AlphaFold · HPA
Whether an antibody against EPHA7 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.32
- Highest tissue expression
- 66 nTPM
Expression across tissuesHPA
Tissue
- parathyroid gland: 66 nTPM
- colon: 11 nTPM
- prostate: 9.1 nTPM
- basal ganglia: 6 nTPM
- kidney: 5.5 nTPM
- cerebral cortex: 5.2 nTPM
Single-cell type
- brain excitatory neurons: 274 nCPM
- brain inhibitory neurons: 239 nCPM
- epididymal efferent duct absorptive cells: 232 nCPM
- lacrimal acinar cells: 227 nCPM
- thyrotrophs: 226 nCPM
- proximal tubule cells: 202 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- cerebral cortex: 13 nTPM
- hippocampal formation: 12 nTPM
- cerebellum: 9.3 nTPM
- basal ganglia: 9.2 nTPM
- hypothalamus: 7.7 nTPM
- midbrain: 7.1 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.13
- gnomAD pLI
- 1
- gnomAD missense Z
- 2.39
- DepMap mean gene effect
- 0.06
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- axon guidance
- brain development
- branching morphogenesis of a nerve
- ephrin receptor signaling pathway
- modulation of chemical synaptic transmission
- negative chemotaxis
- negative regulation of collateral sprouting
- negative regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction
- negative regulation of synapse assembly
- nephric duct morphogenesis
- neuron apoptotic process
- phosphorylation
- positive regulation of neuron apoptotic process
- regulation of cell-cell adhesion
- regulation of ERK1 and ERK2 cascade
- regulation of peptidyl-tyrosine phosphorylation
- regulation of postsynapse organization
- regulation of protein autophosphorylation
- retinal ganglion cell axon guidance
Molecular functions
- ATP binding
- axon guidance receptor activity
- chemorepellent activity
- ephrin receptor binding
- GPI-linked ephrin receptor activity
- growth factor binding
- protein tyrosine kinase activity
- transmembrane-ephrin receptor activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Protein kinase domain
- Ephrin, ligand binding domain
- Serine-threonine/tyrosine-protein kinase, catalytic domain
- Tyrosine-protein kinase, receptor class V, conserved site
- Sterile alpha motif domain
- Fibronectin type III
- Tyrosine-protein kinase, active site
- Galactose-binding-like domain superfamily
- Growth factor receptor cysteine-rich domain superfamily
- Protein kinase-like domain superfamily
- Tyrosine-protein kinase ephrin type A/B receptor-like
- Sterile alpha motif/pointed domain superfamily
- Immunoglobulin-like fold
- Ephrin receptor type-A /type-B
- Protein kinase, ATP binding site
- Tyrosine-protein kinase, catalytic domain
- Ephrin, transmembrane domain
- Fibronectin type III superfamily
- Ephrin receptor tyrosine kinases
- Fibronectin type III domain
- SAM domain (Sterile alpha motif)
- Ephrin receptor ligand binding domain
- Tyrosine-protein kinase ephrin type A/B receptor-like
- Protein tyrosine and serine/threonine kinase
- Ephrin type-A receptor 2 transmembrane domain
- Ephrin cysteine rich domain
- Ephrin type-A receptor 7, ligand binding domain
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of EPHA7 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads EPHA7 as an antibody target. Whether an autoantibody or antibody against EPHA7 could matter depends on whether native EPHA7 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
EPHA7 is annotated at the cell surface, where native EPHA7 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label EPHA7 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...